Business Description
Genprex is an Austin, Texas-based company founded in 2009 that develops gene-based treatments for cancer and diabetes. In oncology, its lead candidate Reqorsa is being tested in multiple clinical trials for lung cancer and has received both Fast Track and Orphan Drug designations from the FDA. For diabetes, the company is working on a therapy that delivers specific genes to the pancreas to restore insulin production, with different approaches for Type 1 and Type 2 patients.
